EVERSANA™ is the leading provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
EVERSANA is developing an integrated and independent commercial services platform designed to solve pricing, access, reimbursement, adherence and product delivery challenges across the life cycle. EVERSANA’s recent activities strengthen its leadership position in the Hub Services market:
- Roivant Sciences named EVERSANA a preferred provider of commercial services worldwide. Under the agreement, EVERSANA and Roivant will partner on opportunities to improve the access, affordability and adherence of innovative therapies developed by Roivant. In addition, EVERSANA and Roivant will expand existing partnerships around multiple Roivant technology platforms, including deploying Alyvant’s salesforce app to enhance results for EVERSANA clients.
- EVERSANA announced partnerships with data and infrastructure companies, including Symphony Health and Compile, to create the industry’s first single, streamlined claims, formulary and physician dataset. The real-time view of the full healthcare system will drive EVERSANA’s end-to-end commercialization services to expedite and optimize targeting, access, adherence and valued outcomes, according to a company press release.
- Datavant and EVERSANA announced a strategic partnership in which EVERSANA will use Datavant’s data linking technology to enhance its advanced analytics capabilities. This partnership will propel powerful analytics through EVERSANA’s fully integrated commercial services platform, helping to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector.
Takeaway: EVERSANA is transforming the commercialization of life science products